SUVN-1702012

N/A

Report date: 2025/01/26 17:17:18
NME

Base Information

Drug NameSUVN-1702012
Drug Alias NameSUVN-1702012
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 7 (5-HT7) receptor modulatorsDopamine D3 receptor modulatorsSerotonin 2a (5-HT2a) receptor modulators +[5] 
TargetsSerotonin 7 (5-HT7) receptorSerotonin 1a (5-HT1a) receptorDopamine D2 receptor +[5] 
Therapy Area/IndicationsMental Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSuven Life Sciences Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSuven Life Sciences Ltd
Inactive CompaniesN/A
Active IndicationsMental Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A